$13.50
-0.10[-0.74%]
At close: May 10
$13.50
0[0.00%]
After Hours: 9:28AM EDT
Alvotech
(NASDAQ:ALVO)Latest News for Alvotech Stock (NASDAQ:ALVO)
Alvotech Stock (NASDAQ: ALVO)
Categories: All
Wednesday, April 24, 2024
Friday, April 19, 2024
- Alvotech shares are trading higher today after the company signed an agreement to expand access to Humira biosimilar Adalimumab-ryvk in the US.Benzinga Newsdesk - Apr 19, 2024, 10:57AM
- Fifth Third Bancorp Reports Upbeat Earnings, Joins Metropolitan Bank Holding, Paramount Global And Other Big Stocks Moving Higher On FridayAvi Kapoor - Apr 19, 2024, 10:40AM
- Alvotech Inks Long-Term Agreement With A Strategic Partner To Further Enhance Access To Adalimumab-ryvk In US MarketBenzinga Newsdesk - Apr 19, 2024, 6:11AM
Tuesday, April 16, 2024
Monday, March 25, 2024
- Alvotech shares are trading lower. The company announced it has increased its share capital by $130,000 by issuing 13,000,000 ordinary shares.Benzinga Newsdesk - Mar 25, 2024, 12:40PM
- Aehr Test Systems Reports Preliminary Results, Joins Dyne Therapeutics, United Airlines And Other Big Stocks Moving Lower On MondayAvi Kapoor - Mar 25, 2024, 10:32AM
Friday, March 22, 2024
Wednesday, March 20, 2024
Tuesday, March 19, 2024
Monday, February 26, 2024
- Why Is Generic Drugs Player Teva Pharma Stock Trading Higher Today?Vandana Singh - Feb 26, 2024, 8:48AM
- Alvotech shares are trading higher after the company announced the FDA approved its arthritis treatment.Luke J Jacobi - Feb 26, 2024, 8:30AM
- Late Friday, Alvotech And Teva Pharmaceutical Industries Announced That FDA Approved Simlandi (Adalimumab-ryvk) Injection, As An Interchangeable Biosimilar To AbbVie's Arthritis Drug HumiraBenzinga Newsdesk - Feb 26, 2024, 7:22AM
- Alvotech Has Accepted An Offer From Investors For The Sale Of 10.13M Shares, For Approximately $166M At $16.41/Share Or ISK 2,250/Share; The Transaction Will Be Made On The Nasdaq Iceland ExchangeBenzinga Newsdesk - Feb 26, 2024, 4:31AM
Monday, January 29, 2024
- American Airlines To Rally Around 32%? Here Are 10 Top Analyst Forecasts For MondayAvi Kapoor - Jan 29, 2024, 7:34AM
- Barclays Upgrades Alvotech to Overweight, Raises Price Target to $17Benzinga Newsdesk - Jan 29, 2024, 5:21AM
- Alvotech Announces Top-Line Results from a Pharmacokinetic Study for AVT03, a Proposed Biosimilar for Prolia and XgevaBenzinga Newsdesk - Jan 29, 2024, 4:02AM
Friday, January 19, 2024
- Alvotech shares are trading higher after the company announced that the reinspection of its Iceland facility by the FDA has been concluded.Benzinga Newsdesk - Jan 19, 2024, 2:24PM
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Jan 19, 2024, 12:31PM
- Alvotech Provides Update On Status Of Biologics License Applications For AVT02 And AVT04Benzinga Newsdesk - Jan 19, 2024, 11:31AM
Wednesday, January 10, 2024
Wednesday, January 03, 2024
Wednesday, November 29, 2023
Tuesday, November 28, 2023
- Alvotech Nine Months Of 2023 EPS $(1.21) Down From $(1.00) YoY, Product Revenue $29.800M Up From $11.060M YoYBenzinga Newsdesk - Nov 28, 2023, 4:29PM
- Alvotech Reports Financial Results For 9-Months Of 2023 And Provides A Business Update; 9-Month EPS $(1.21); Revenue $29.8MBenzinga Newsdesk - Nov 28, 2023, 4:28PM
- Earnings Scheduled For November 28, 2023Benzinga Insights - Nov 28, 2023, 4:33AM
Monday, November 27, 2023
Friday, November 10, 2023
Friday, October 20, 2023
Thursday, October 12, 2023
Tuesday, October 03, 2023
Monday, September 25, 2023
Thursday, September 21, 2023
Wednesday, September 20, 2023
Tuesday, September 05, 2023
Wednesday, August 30, 2023
Monday, July 24, 2023
- Alvotech shares are trading higher after the company and Teva Pharmaceuticals announced they agreed to expand their existing strategic partnership agreement.Benzinga Newsdesk - Jul 24, 2023, 8:34AM
- Teva Pharmaceuticals, Alvotech Expand Their Existing Strategic Biosimilars PartnershipBenzinga Newsdesk - Jul 24, 2023, 4:07AM